| Overview |
| bsm-61844r |
| E2F6 Recombinant Antibody |
| WB, Flow-Cyt, ICC/IF |
| Human |
| Specifications |
| Unconjugated |
| Rabbit |
| KLH conjugated synthetic peptide derived from human E2F6 |
| Recombinant |
| IgG |
| Lot dependent |
| Purified by Protein A. |
| 0.01M TBS (pH 7.4), 1% BSA, 0.02% Proclin 300, and 50% Glycerol |
| Shipped at 4C. Store at -20C for one year. Avoid repeated freeze/thaw cycles. |
| Target |
| 1876 |
| O75461 |
| E2F 6; E2F-6; E2F6; EMA. |
| Inhibitor of E2F-dependent transcription. Binds DNA cooperatively with DP proteins through the E2 recognition site, 5'-TTTC[CG]CGC-3'. Has a preference for the 5'-TTTCCCGC-3' E2F recognition site. E2F-6 lacks the transcriptional activation and pocket protein binding domains. |
| Application Dilution |
| WB |
1:300-5000 |
| Flow-Cyt |
FCM1:20-100 |
| ICC/IF |
IFICC1:50-200 |
Powered by Bioz